Successful Treatment of Post‐SARS‐CoV‐2 Infection Reactive Arthritis With Secukinumab: A Case Report and Literature Review
This case describes a rare occurrence of post-SARS-CoV-2 infection reactive arthritis with psoriasiform lesions. The patient failed to respond to conventional therapies but responded well to secukinumab, underscoring that it may be a valuable treatment for refractory post-SARS-CoV-2 infection reactive arthritis when conventional therapies fail.
Authors
- Jie Hu (ORCID: https://orcid.org/0000-0001-6451-4164)
- Xing Fan (ORCID: https://orcid.org/0000-0002-0809-9207)
- Lili Tang (ORCID: https://orcid.org/0000-0002-5269-3297)
- Xiangning Li (ORCID: https://orcid.org/0000-0002-3747-2824)
- Ruyi Wang
- Tianyu Yao
- Chengyu Li (ORCID: https://orcid.org/0000-0001-5361-4442)
- Yulin Wang (ORCID: https://orcid.org/0009-0002-2940-1150)
- Yiyang Hu
- Danyue He
- Zhao Qi
- Cai Jia
Institutions
- Anhui University (CN)
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/ccr3.71355
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00